Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Catheter-Directed Embolectomy Could Be a Life-Saver

By HospiMedica International staff writers
Posted on 02 Sep 2008
Patients suffering a massive pulmonary embolism (PE) who fail to respond to or cannot receive systemic thrombolysis could be saved by a catheter-directed intervention (CDI), claims a new study.

Researchers from Stanford University Medical Center (Stanford, CA, USA) conducted a retrospective review of 70 consecutive patients with suspected acute PE over a 10-year period (1997-2006) who had been referred for pulmonary angiography or intervention. More...
The criteria for study inclusion were patients who received CDI due to angiographically confirmed massive PE and hemodynamic shock. The CDI involved suction embolectomy and fragmentation, with or without catheter thrombolysis. In all, 12 patients (7 men and 5 women; mean age 56 years) were treated with CDI. Seven patients (58%) were referred for CDI after failing systemic infusion with 100 mg of tissue plasminogen activator (tPA), and five patients (42%) had contraindications to systemic thrombolysis.

The study found that CDI fragmentation and embolectomy were performed in all 12 patients, and catheter-guided thrombolysis was performed in eight patients (67%). Technical success was achieved in all cases, and there were no major procedural complications. Two patients (17%) died secondary to cardiac arrest within 24 hours. The other patients showed significant hemodynamic improvement, survived the procedure, and remained stable until hospital discharge. There were minor complications in two patients, a groin hematoma in one and transient bradycardia during activation of the rheolytic catheter in the other patient. The study was published in the August 2008, issue of the journal Chest.

"In the setting of hemodynamic shock from massive PE, catheter-directed intervention may be performed with or without local thrombolysis and may be useful in patients who have not responded to or cannot tolerate thrombolysis,” concluded lead author William Kuo, M.D., and colleagues of the division of vascular and interventional radiology. "We need to figure out exactly which patients with sub-massive PE are appropriate candidates for intervention. This treatment is likely to be much safer and more effective than standard treatment with intravenous tPA.”

Related Links:
Stanford University Medical Center


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.